| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 158,5 M € | -1.7% | 161,2 M € | -5.9% | 171,3 M € | -0.8% | 172,7 M € | +4.1% | 165,9 M € | +459.4% | 29,7 M € | +4.4% | 28,4 M € | +9.1% | 26,0 M € | +10.4% | 23,6 M € | +7.0% | 22,0 M € | -3.4% | 22,8 M € | +12.4% | 20,3 M € | +4.2% | 19,4 M € | +0.2% | 19,4 M € | +2.7% | 18,9 M € | -0.2% | 18,9 M € | +6.2% | 17,8 M € | +9.4% | 16,3 M € | |
| EBITDA | 8,8 M € | -20.6% | 11,0 M € | -36.7% | 17,4 M € | +106.9% | 8,4 M € | -42.1% | 14,5 M € | +1022.3% | 1,3 M € | +69.9% | 762,9 k € | -36.7% | 1,2 M € | -12.8% | 1,4 M € | +425.6% | 262,8 k € | -22.6% | 339,6 k € | -68.2% | 1,1 M € | +1.1% | 1,1 M € | +18.9% | 889,1 k € | +10.1% | 807,6 k € | -9.0% | 887,2 k € | +27.4% | 696,2 k € | +10.2% | 631,9 k € | |
| Operating profit | 7,0 M € | -35.7% | 10,9 M € | -11.6% | 12,4 M € | +16.6% | 10,6 M € | -20.3% | 13,3 M € | +931.2% | 1,3 M € | +71.1% | 753,8 k € | -37.7% | 1,2 M € | -10.6% | 1,4 M € | +469.0% | 237,7 k € | -30.6% | 342,6 k € | -67.0% | 1,0 M € | -1.4% | 1,1 M € | +21.5% | 865,4 k € | +8.7% | 796,1 k € | -8.4% | 869,1 k € | +29.6% | 670,4 k € | +8.8% | 616,1 k € | |
| Profit/loss | 4,9 M € | -43.3% | 8,6 M € | -15.1% | 10,1 M € | +27.5% | 7,9 M € | -21.5% | 10,1 M € | +547.1% | 1,6 M € | +57.5% | 987,7 k € | -25.0% | 1,3 M € | +2.2% | 1,3 M € | -93.8% | 20,8 M € | +1646.7% | 1,2 M € | -16.2% | 1,4 M € | -4.9% | 1,5 M € | -12.6% | 1,7 M € | -0.4% | 1,7 M € | +9.2% | 1,6 M € | -20.8% | 2,0 M € | +7.0% | 1,9 M € | |
| Equity | 21,9 M € | -35.7% | 34,0 M € | +33.6% | 25,5 M € | -16.2% | 30,4 M € | -14.4% | 35,5 M € | -31.3% | 51,7 M € | +3.1% | 50,1 M € | -1.0% | 50,6 M € | +2.7% | 49,3 M € | -38.4% | 80,0 M € | +35.2% | 59,2 M € | +2.1% | 58,0 M € | +2.5% | 56,6 M € | +2.7% | 55,1 M € | +3.2% | 53,4 M € | +3.3% | 51,7 M € | -1.0% | 52,2 M € | +6.6% | 48,9 M € | |
| Total assets | 46,1 M € | +16.9% | 39,5 M € | -26.5% | 53,7 M € | +0.1% | 53,6 M € | -46.9% | 101,0 M € | +88.7% | 53,5 M € | +4.4% | 51,3 M € | -2.2% | 52,4 M € | +3.5% | 50,7 M € | -37.6% | 81,1 M € | +35.3% | 60,0 M € | +0.9% | 59,4 M € | +2.4% | 58,0 M € | +3.0% | 56,3 M € | +2.4% | 55,0 M € | +3.4% | 53,2 M € | -2.0% | 54,3 M € | +7.4% | 50,5 M € | |
| Cash | — | — | 27,5 M € | +16.2% | 23,7 M € | -63.8% | 65,4 M € | +1373.8% | 4,4 M € | +425.1% | 845,6 k € | -75.4% | 3,4 M € | +131.0% | 1,5 M € | -95.4% | 32,3 M € | +197.7% | 10,8 M € | +50.2% | 7,2 M € | -28.4% | 10,1 M € | +38.9% | 7,3 M € | +185.5% | 2,5 M € | +223.7% | 785,2 k € | -4.6% | 823,2 k € | -31.8% | 1,2 M € | |||
| Debts | 22,0 M € | +380.7% | 4,6 M € | -79.2% | 22,0 M € | +4.1% | 21,2 M € | -63.7% | 58,2 M € | +5106.3% | 1,1 M € | +134.1% | 477,7 k € | -63.4% | 1,3 M € | +53.1% | 852,3 k € | +32.3% | 644,3 k € | -17.5% | 781,0 k € | -45.0% | 1,4 M € | -1.6% | 1,4 M € | +15.2% | 1,3 M € | -23.6% | 1,6 M € | +5.7% | 1,6 M € | -22.0% | 2,0 M € | +33.0% | 1,5 M € | |
| Staff | 46,3 | 47,1 | 45,6 | 43,4 | 23,2 | 8,9 | 8 | 8 | 7,9 | 8,3 | 10 | 10,3 | 8,6 | 11,6 | 19,3 | 19,3 | 19,4 | 15 | ||||||||||||||||||
Private limited company · Hoeilaart · incorporated on 16/03/1984 · 46,3 ETP
Private limited company profitable and well capitalised. Cash position rising (+16.2%).
Solid counterparty for a standard engagement.
MERCK LIFE SCIENCE is a Private limited company incorporated in 1984. Its main activity is: Wholesale of chemical products. Its registered office is in Hoeilaart. It employs on average 46,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette